Related Experiment Video
Updated: Aug 1, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
A practical guide to antiretroviral drug use
1University of South Florida School of Medicine, Tampa, USA.
Contemporary Internal Medicine
|February 7, 1995
Summary
Antiretroviral therapy benefits HIV patients with low CD4 counts, but effects are temporary and depend on initial immune status. Viral replication persists even during clinical latency.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Human Immunodeficiency Virus (HIV) infection leads to immune suppression.
- Antiretroviral therapies (ART) are standard care for HIV.
- Understanding the long-term impact of ART based on immune status is crucial.
Purpose of the Study:
- To evaluate the efficacy of antiretroviral agents in HIV patients.
- To determine the influence of baseline immune status on treatment outcomes.
- To investigate viral replication during clinical latency.
Main Methods:
- Analysis of patient data including CD4 counts.
- Longitudinal monitoring of treatment effects.
- Assessment of viral load during different disease stages.
Main Results:
- ART shows benefits for HIV patients with CD4 counts below 500 cells/mm3.
- Treatment effects are time-limited.
- Outcomes are significantly related to the patient's baseline immune status.
- Active viral replication was detected during clinical latency periods.
Conclusions:
- ART is beneficial but not curative for HIV.
- Treatment duration and effectiveness are modulated by initial immune health.
- Continuous monitoring for viral activity is necessary even in latent phases.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:15Drug Dosage Regimen: Overview
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...